Empagliflozin Reduced Colon Fibrosis in Lab Study
Researchers found that the medication activated fatty acid metabolism and lowered fibrosis gene expression in mice.
Updated on Sept. 23, 2026 in Nutrition
Live Poll
Does new research on diet and metabolic health influence your personal dietary choices?
A laboratory study found that administering empagliflozin to mice on a Western diet activated colonic fatty acid metabolism and reduced fibrosis-related gene expression. Researchers evaluated the interaction between the drug and diet to understand how it influences metabolic deterioration.
Why it matters
The study investigated the impact of empagliflozin on intestinal transcriptomics and the gut microbiome to determine how it mitigates diet-induced metabolic damage. These findings offer insight into how specific drugs may interact with diet to manage internal health markers.
Researchers identified 1,136 interacting genes in the colon after a 10-week intervention, with interaction effects demonstrating a PERMANOVA statistical significance of p = 0.001.
The players
C57BL/6J mice
These are a common inbred strain of laboratory mice used as a model organism in biomedical research.
The details
The analysis utilized transcriptomics and 16S amplicon sequencing to observe how empagliflozin influences regulators such as Peroxisome proliferator-activated receptor alpha and Nuclear factor kappa B subunit p65. Findings indicated that while a Western diet typically reduces microbiome alpha diversity, the drug treatment helped counteract specific fibrotic gene expressions.
Timeline
The diet and drug intervention for the mouse subjects lasted for 10 weeks.
The Big Picture
This study follows a pattern established by the investigation of SGLT2 inhibitors in metabolic health, extending the scope of the drug beyond its traditional use. By focusing on intestinal transcriptomics, it marks a departure from purely glycemic studies toward broader metabolic systemic regulation.
These results provide insight into the potential secondary benefits of existing medications but should not alter daily health routines. Readers should consult with a medical professional regarding any changes to treatment plans or the management of diet-related health conditions.
The takeaway
Preclinical findings often highlight biological pathways that require extensive further study before they can be applied to human health outcomes. Understanding how medications interact with dietary intake is a developing area of focus for managing chronic metabolic conditions.
Further reading
Learn more about the latest research on dietary influences in the Nutrition section.
More information
Review the peer-reviewed research article for comprehensive methodology and data.
Source note: This article includes information reported by Nature.
Live Poll
Does new research on diet and metabolic health influence your personal dietary choices?
